You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Litigation Details for Cadence Pharmaceuticals Inc. v. InnoPharma Licensing LLC (D. Del. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Cadence Pharmaceuticals Inc. v. InnoPharma Licensing LLC (D. Del. 2014)

Docket   Start Trial Date Filed 2014-09-24
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Patents 6,028,222; 6,992,218
Attorneys A. Claire Frezza; Dominick T. Gattuso; Eric H. Weisblatt; Jeremy A. Tigan; John B. Wyss; Karin A. Hessler; Mark A. Pacella; Robert J. Scheffel; Stephen J. Kraftschik; Thomas C. Grimm
Link to Docket External link to docket
Small Molecule Drugs cited in Cadence Pharmaceuticals Inc. v. InnoPharma Licensing LLC
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Cadence Pharmaceuticals Inc. v. InnoPharma Licensing LLC (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2016-07-08 215 alleging infringement of U.S. Patent Nos. 6,028,222 (the '"222 patent") and 6,992,218 (the …the '"218 patent"). The patents claim aqueous acetaminophen formulations and methods for …quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the… During the reexamination of the '222 patent, the Patent Examiner found that the broadest reasonable…ultimate question of the proper construction of a patent is a question oflaw. See Teva Pharm. USA, Inc. External link to document
2014-09-24 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,028,222; 6,992,218 B2. (etg…24 September 2014 1:14-cv-01225 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.